DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Opioid modulator
Opioid modulator
52Nd Annual Meeting
Behavioral and Brain Sciences Plasticity: Implications for Opioid
Design and Synthesis of Functionally Selective Kappa Opioid Receptor Ligands
Opioids Regulate Cgmp Formationin Cloned Neuroblastoma Cells
Npp2013281.Pdf
IRL Grey- B 12/28/2016 1 Protocol Version 6
Poster Abstr Acts May 28 – 31, 2013 Wednesday, May 29, 2013 Poster Session I Regency 1 Ballroom
Bi-Phasic Dose Response in the Preclinical and Clinical Developments of Sigma-1 Receptor Ligands for the Treatment of Neurodegenerative Disorders Tangui Maurice
Tuesday, June 23, 2015
14-113 Phrma Mentalhealth2014 0501.Indd
Investigation of Membrane Receptors' Oligomers Using Fluorescence Resonance Energy Transfer and Multiphoton Microscopy in Living Cells”, UW-Milwaukee, Dec 2016 2
NOVEL APPROACHES to IMPROVING OPIOID ANALGESIC THERAPY by David Isaiah Duron Copyright © David Isaiah Duron 2020 a Dissertation
Alkermes Announces Data on ALKS 5461 and ALKS 3831 to Be Presented at 53Rd Annual NCDEU Meeting
Role of Opioid Receptors in Bombesin-Induced Grooming“
4Th Meeting Program and Abstract Book
PROGRAM BOOK Table of Contents
Opiate Receptor Subtypes and Brain Function
Autoradiographic Differentiation of Mu, Delta, and Kappa Opioid Receptors in the Rat Forebrain and Midbrain
Top View
057196 N.W. Chlorine Powder-5
In the Circuit Court
Alkermes Initiates Two New Clinical Trials of ALKS 33
(12) United States Patent (10) Patent No.: US 7,576,207 B2 Dolle Et Al
Cha Kuin Taiteit Van Die Man En Minuman
( 12 ) United States Patent
Tramadole Classification of Pain by Onset and Duration Acute Pain Sudden in Onset Usually Subsides Once Treated
G Proteinactivation
Poster Session III Neurochemical, and Genetic Aspects of Schizophrenia and Psychosis December 8, 2010 5:30PM-7:30 PM Than Current Models Is Highly Desirable
Meeting Program
NDSP Catalog 23Rd Edition
Buprenorphine/Samidorphan (BUP/SAM) NDA 210,417
WO 2017/015309 Al 26 January 2017 (26.01.2017) P O P C T
Exploring the N-Benzylpiperidine and N, N-Dibenzyl(N-Methyl)
Alkermes Announces Positive Results from Phase 1 Study of ALKS 33 in Combination with Buprenorphine for Treatment of Cocaine Addiction
100 Drugs-Trade-7:18:19